Boreal Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Boreal Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.13K	Hold	122	–	–	﹤0.01%	419
2026 Q1	$3.67K	Hold	122	–	–	﹤0.01%	420
2025 Q4	$3.81K	Sell	122 -200	-62%	-$4.93K	﹤0.01%	440
2025 Q3	$6.5K	Sell	322 -100	-24%	-$1.76K	0.01%	415
2025 Q2	$7.07K	Buy	+422	New	+$6.81K	0.01%	378

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Boreal Capital Management's TEVA Position: Q2 2026 in Review

Boreal Capital Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 122 shares worth $4.13K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Boreal Capital Management first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.07K in Q2 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Boreal Capital Management held 122 shares of Teva Pharmaceutical Industries Limited worth $4.13K as of Q2 2026.
Boreal Capital Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Boreal Capital Management's portfolio in Q2 2026, its #419 holding.
Boreal Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2025 and has held it in 5 quarters since.
Boreal Capital Management's Teva Pharmaceutical Industries Limited position peaked at $7.07K in Q2 2025.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Boreal Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.